Halozyme Therapeutics shares owned by Birchview Capital
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Birchview Capital
from 13F filings
Historical chart of Birchview Capital investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Birchview Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $741k | 10k | 73.34 |
| 2025-06-30 | $520k | 10k | 52.02 |
| 2025-03-31 | $638k | 10k | 63.81 |
| 2024-12-31 | $478k | 10k | 47.81 |
| 2024-09-30 | $572k | 10k | 57.24 |
| 2024-06-30 | $524k | 10k | 52.36 |
| 2024-03-31 | $407k | 10k | 40.68 |
| 2023-12-31 | $370k | 10k | 36.96 |
| 2023-09-30 | $382k | 10k | 38.20 |
| 2023-06-30 | $361k | 10k | 36.07 |
| 2023-03-31 | $382k | 10k | 38.20 |
| 2022-12-31 | $569k | 10k | 56.90 |